[EN] CXCR4 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE CXCR4 ET LEURS UTILISATIONS
申请人:X4 PHARMACEUTICALS INC
公开号:WO2021263203A1
公开(公告)日:2021-12-30
The present invention relates to compounds and methods of inhibiting C-X-C receptor type 4 (CXCR4). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various diseases.
Catalytic Asymmetric Redox‐Neutral [3+2] Photocycloadditions of Cyclopropyl Ketones with Vinylazaarenes Enabled by Consecutive Photoinduced Electron Transfer
ConPET as a powerful and novel technique for photoredox catalysis has been first employed in asymmetric synthesis. In collaboration with chiral hydrogen-bonding catalysis, an unprecedented redox-neutral [3+2] photocycloaddition has been developed, facilitating the synthesis of a wide range of valuable azaarene-functionalized cyclopentyl ketones with high yields, ees and dr.